Patient info Open main menu

Finasteride 1 mg tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
1 mg
Contains active substance:

Patient leaflet - Finasteride 1 mg tablets

1. What Finasteride Tablets are and what they are used for

Finasteride Tablets contain a medicine called finasteride. This belongs to a group of medicines called Type II '5-alpha reductase inhibitors'.

Finasteride Tablets are used for the treatment of male pattern hair loss (also known as androgenetic alopecia). Finasteride Tablets increase hair growth on the scalp and prevent further hair loss in men. Men with mild to moderate, but not complete hair loss, can benefit from using Finasteride Tablets.

How does the hair on your head grow?

On average your hair grows about 1 centimetre (half an inch) each month. Hair grows from hair follicles, which are located under your skin.

2. What you need to know before you take Finasteride Tablets

Do not take Finasteride Tablets if:

  • You are a woman (because this medicine

    is for men). It has been shown in clinical trials that Finasteride Tablets do not work in women with hair loss.

  • You are allergic (hypersensitive) to

    finasteride or any of the other ingredients of this medicine (listed in section 6)

  • You are already taking finasteride or

    dutasteride used for a prostate problem called benign prostatic hyperplasia (BPH). Do not take Finasteride Tablets if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist.

Warnings and precautions

Talk to your doctor or pharmacist before taking Finasteride Tablets if:

  • You are going to have a blood test for

    prostate cancer called PSA (prostate -specific antigen). This is because Finasteride Tablets can affect the result of this test.

Effects on fertility

Infertility has been reported in men who took finasteride for long time and had other risk factors that may affect fertility. Normalisation or improvement of seminal quality has been reported after discontinuation of finasteride. Long-term clinical studies about the effects of finasteride on fertility in men have not been conducted.

Breast Cancer

See section 4.

Mood alterations and depression

Mood alterations such as depressed mood, depression and less frequently, suicidal thoughts have been reported in patients treated with Finasteride Tablets. If you experience any of these symptoms stop taking Finasteride Tablets and contact your doctor for further medical advice as soon as possible.

Impaired sexual function that may contribute to mood alterations, including suicidal thoughts, has been reported in some patients. If you experience symptoms of impaired sexual function, contact your doctor for further medical advice. Your doctor may consider stopping the treatment (see section 4 below for more information about these side effects).

Information on sodium content

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.

3. How to take Finasteride Tablets

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

  • The recommended dose is one tablet

    each day. The tablet can be taken with or without food.

If you take more Finasteride Tablets than you should

If you take too many tablets by mistake, contact your doctor immediately. Finasteride Tablets will not work faster or better if you take them more than once a day.

If you forget to take Finasteride Tablets

  • Do not take a double dose to make up for

    a forgotten dose.

If you stop taking Finasteride Tablets

It may take 3 to 6 months for the full effect to develop. It is important to keep taking Finasteride Tablets for as long as your doctor tells you. If you stop taking Finasteride Tablets, you are likely to lose the hair you have gained within 9 to 12 months.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. Some of the side effects are temporary with continued treatment or disappear when treatment is stopped.

Stop taking Finasteride Tablets and talk to your doctor immediately if you have any of the following:

  • Symptoms of an allergic reaction: swelling

    of your lips, face, tongue and throat; difficulty swallowing; lumps under your skin (hives) and breathing difficulties

  • Depression (feelings of severe sadness

    and unworthiness)

  • Suicidal thoughts.

296 mm

  • The number of men who developed prostate

    cancer was lower in men taking finasteride compared with those taking nothing.

  • The number of men who had a high score

    in a tumour grading system was higher in some of those taking finasteride compared to those taking nothing.

  • The effect of long-term use of finasteride

    on tumours of this kind is unknown.

  • If you would like further information about

    the tumour grading system or this trial, please talk to your doctor.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Finasteride Tablets

Keep this medicine out of the sight and reach of children.

Do not use Finasteride Tablets after the expiry date which is stated on the blister, carton or bottle. The expiry date refers to the last day of that month.

This medicinal product does not require any special storage conditions.

Do not put the tablets into another container, they might get mixed up. Do not remove the tablet from the pack until you are ready to take it.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Finasteride Tablets contain

The active substance is finasteride 1 mg. The other ingredients are:

Tablet core: Lactose monohydrate, microcrystalline cellulose, pregelatinised starch, lauroyl macrogolglycerides, sodium starch gycolate (Type A) and magnesium stearate.

Tablet coating: Hypromellose, titanium dioxide (E171), yellow and red iron oxide (E172) and macrogol 6000.

What Finasteride Tablets look like and contents of the pack

Finasteride Tablets are round, biconvex reddish-brown tablets, with the markings ‘F1’.

They are supplied in:

Blister packs containing 28 and 84 tablets. Plastic bottles containing 28 tablets.

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer

Relonchem Limited, Cheshire House, Gorsey Lane, Widnes, Cheshire, WA8 0RP, UK.

Product Licence Number: PL 20395/0068

This leaflet was last revised in February 2026.

POM

296 mm

You should promptly report to your doctor any changes in your breast tissue such as lumps, pain, enlargement or nipple discharge as these may be signs of a serious condition, such as breast cancer.

Uncommon: may affect up to 1 in 100 people

  • You may be unable to have an erection

    (impotence)

  • You may have less desire to have sex
  • You may have problems with ejaculation, for example a decrease in the amount of semen released during sex. This decrease in the amount of semen does not appear to affect normal sexual function.
  • Depression.

Not known: frequency cannot be estimated from the available data

  • Breast swelling or tenderness
  • Palpitations (feeling your heartbeat)
  • Changes in the way your liver is working, which can be shown by a blood test
  • Pain in the testicles
  • Blood in semen
  • Persistent difficulty having an erection after discontinuation of treatment
  • Persistent decrease in sex drive after discontinuation of treatment
  • Persistent problems with ejaculation after discontinuation of treatment
  • Male infertility and/or poor quality of semen
  • Anxiety
  • Suicidal thoughts.

If any of these side effects gets serious, or if you notice any side effects not listed on this leaflet please tell your doctor or pharmacist. It will help if you make a note of what happened, when it started and how long it lasted. Will the use of Finasteride Tablets affect the hair on other parts of your body?

Finasteride Tablets do not affect hair on other parts of the body.

What else should you know about Finasteride Tablets?

Finasteride can also be used for a type of prostate problem called ‘benign prostatic hyperplasia’ or BPH. Information collected from a clinical trial in men taking finasteride 5 mg (a dose 5 times higher than Finasteride Tablets) for 7 years showed:

Impaired sexual function has also been reported without mood alterations or suicidal thoughts. A patient card reminding of the above is provided with the package of Finasteride.

Children and adolescents

Finasteride Tablets should not be used in children. There are no data demonstrating efficacy or safety of finasteride in children under the age of 18.

Other medicines and Finasteride Tablets

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Finasteride Tablets do not usually affect other medicines.

  • Do not take Finasteride Tablets if you are

    already taking finasteride or dustasteride, used for a prostate problem called benign prostatic hyperplasia (BPH).

  • No information is available about the use

    of Finasteride Tablets with minoxidil, another type of medicine for male pattern hair loss which is applied to the head.

Pregnancy, breast-feeding and fertility

Finasteride Tablets are for the treatment of male pattern hair loss in men only. For effects on fertility see section 2.

  • Finasteride Tablets should not be taken

    by women.

  • Do not touch crushed or broken Finasteride

    Tablets if you are a woman who is pregnant or planning to become pregnant (whole tablets are coated to stop contact with the medicine during normal use). This is because this medicine may affect the baby’s sex organs.

  • If a woman who is pregnant comes into

    contact with crushed or broken Finasteride Tablets, speak to your doctor.

Driving and using machines

Finasteride Tablets are not likely to affect you being able to drive, use tools or machines.

Finasteride Tablets contain Lactose

If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 20395/0068

Last revision stated in the text: February 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Finasteride 1 mg tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Finasteride
Strength 1 mg
Pharmaceutical form Oral tablet
Round biconvex, reddish brown tablets 7 mm in diameter, marked “F1”.
How is it taken Oral
Excipients Lactose monohydrate, Cellulose, microcrystalline, Pregelatinised starch, Lauroyl macrogolglycerides, Sodium starch glycolate - Type A, Magnesium stearate, Hypromellose 6 cps., Titanium dioxide (E171), Iron oxide yellow E 172, Iron oxide red E 172, Macrogol 6000
Pack sizes 28 tablet, 84 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years
Storage This medicinal product does not require any special storage conditions
Drug group (ATC) 5α-reductase inhibitor
  1. D Dermatologicals
    1. D11 Other dermatological preparations
      1. D11A Other dermatological preparations
        1. D11AX Other dermatological preparations
          1. D11AX10 finasteride
Marketing authorisation PL 20395/0068 (first authorised 11 September 2008)
Marketing authorisation holder Relonchem Limited
Codes GTIN 5055144201375, 5055144201382 · BNF 13090000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.